Persistent expression of Pax3 in the neural crest causes cleft palate and defective osteogenesis in mice.

Transcription factors regulate tissue patterning and cell fate determination during development; however, expression of early regulators frequently abates upon differentiation, suggesting that they may also play a role in maintaining an undifferentiated phenotype. The transcription factor paired box 3 (Pax3) is expressed by multipotent neural crest precursors and is implicated in neural crest disorders in humans such as Waardenburg syndrome. Pax3 is required for development of multiple neural crest lineages and for activation of lineage-specific programs, yet expression is generally extinguished once neural crest cells migrate from the dorsal neural tube and differentiate. Using a murine Cre-inducible system, we asked whether persistent Pax3 expression in neural crest derivatives would affect development or patterning. We found that persistent expression of Pax3 in cranial neural crest cells resulted in cleft palate, ocular defects, malformation of the sphenoid bone, and perinatal lethality. Furthermore, we demonstrated that Pax3 directly regulates expression of Sostdc1, a soluble inhibitor of bone morphogenetic protein (BMP) signaling. Persistent Pax3 expression renders the cranial crest resistant to BMP-induced osteogenesis. Thus, one mechanism by which Pax3 maintains the undifferentiated state of neural crest mesenchyme may be to block responsiveness to differentiation signals from the environment. These studies provide in vivo evidence for the importance of Pax3 downregulation during differentiation of multipotent neural crest precursors and cranial development.

[1]  T. Rando,et al.  Regulation of Pax3 by Proteasomal Degradation of Monoubiquitinated Protein in Skeletal Muscle Progenitors , 2007, Cell.

[2]  S. Murray,et al.  Multiple functions of Snail family genes during palate development in mice , 2007, Development.

[3]  R. Stein,et al.  Ptf1a Binds to and Activates Area III, a Highly Conserved Region of the Pdx1 Promoter That Mediates Early Pancreas-Wide Pdx1 Expression , 2007, Molecular and Cellular Biology.

[4]  J. Davis Bioinformatics and Computational Biology Solutions Using R and Bioconductor , 2007 .

[5]  A. Gritli-Linde Molecular control of secondary palate development. , 2007, Developmental biology.

[6]  Y. Chai,et al.  Recent advances in craniofacial morphogenesis , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[7]  C. Mayanil,et al.  Regulation of Murine TGFβ2 by Pax3 during Early Embryonic Development* , 2006, Journal of Biological Chemistry.

[8]  K. Shiota,et al.  Regional heterogeneity in the developing palate: morphological and molecular evidence for normal and abnormal palatogenesis , 2006, Congenital anomalies.

[9]  C. Mayanil,et al.  Regulation of murine TGFbeta2 by Pax3 during early embryonic development. , 2006, The Journal of biological chemistry.

[10]  R. Schneider,et al.  Neural crest cells and the community of plan for craniofacial development: historical debates and current perspectives. , 2006, Advances in experimental medicine and biology.

[11]  J. Epstein,et al.  Cardiac neural crest. , 2005, Seminars in cell & developmental biology.

[12]  P. Trainor,et al.  Relations and interactions between cranial mesoderm and neural crest populations , 2005, Journal of anatomy.

[13]  Charlotte Collins,et al.  Direct Isolation of Satellite Cells for Skeletal Muscle Regeneration , 2005, Science.

[14]  Z. Kozmík Pax genes in eye development and evolution. , 2005, Current opinion in genetics & development.

[15]  J. Epstein,et al.  Insertion of Cre into the Pax3 locus creates a new allele of Splotch and identifies unexpected Pax3 derivatives. , 2005, Developmental biology.

[16]  J. Epstein,et al.  Pax3 functions at a nodal point in melanocyte stem cell differentiation , 2005, Nature.

[17]  F. Melchers B cell development and its deregulation to transformed states at the pre-B cell receptor-expressing pre-BII cell stage. , 2005, Current topics in microbiology and immunology.

[18]  S. Creuzet,et al.  Neural crest derivatives in ocular and periocular structures. , 2005, The International journal of developmental biology.

[19]  Gordon K. Smyth,et al.  limma: Linear Models for Microarray Data , 2005 .

[20]  A. McMahon,et al.  Disruption of Fgf10/Fgfr2b-coordinated epithelial-mesenchymal interactions causes cleft palate. , 2004, The Journal of clinical investigation.

[21]  G. Stein,et al.  Runx2/Cbfa1: a multifunctional regulator of bone formation. , 2003, Current pharmaceutical design.

[22]  J. Epstein,et al.  Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer. , 2003, Human molecular genetics.

[23]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[24]  T. Rando,et al.  The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. , 2002, Developmental cell.

[25]  E. Pennisi Evo-Devo Devotees Eye Ocular Origins and More , 2002, Science.

[26]  J. Deng,et al.  The Novel Zinc Finger-Containing Transcription Factor Osterix Is Required for Osteoblast Differentiation and Bone Formation , 2002, Cell.

[27]  F. Barr,et al.  Molecular Pathogenesis of Rhabdomyosarcoma , 2002, Cancer biology & therapy.

[28]  J. Epstein,et al.  Getting your Pax straight: Pax proteins in development and disease. , 2002, Trends in genetics : TIG.

[29]  N. Kanatani,et al.  Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures , 2001, The Journal of cell biology.

[30]  F. Guillemot,et al.  Pax6 Is Required for the Multipotent State of Retinal Progenitor Cells , 2001, Cell.

[31]  J. Kerrigan,et al.  Palatogenesis and potential mechanisms for clefting. , 2000, Journal of the Royal College of Surgeons of Edinburgh.

[32]  J. Wozney,et al.  Runx2 Is a Common Target of Transforming Growth Factor β1 and Bone Morphogenetic Protein 2, and Cooperation between Runx2 and Smad5 Induces Osteoblast-Specific Gene Expression in the Pluripotent Mesenchymal Precursor Cell Line C2C12 , 2000, Molecular and Cellular Biology.

[33]  J. Epstein,et al.  Pax3 is required for enteric ganglia formation and functions with Sox10 to modulate expression of c-ret. , 2000, The Journal of clinical investigation.

[34]  M. Kelz,et al.  Overexpression of ΔFosB transcription factor(s) increases bone formation and inhibits adipogenesis , 2000, Nature Medicine.

[35]  W. Pavan,et al.  Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3 , 2000, Human Genetics.

[36]  A. McMahon,et al.  Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. , 2000, Development.

[37]  J. Epstein,et al.  Gene expression analysis by in situ hybridization. Radioactive probes. , 2000, Methods in molecular biology.

[38]  L. Quarles,et al.  Cbfa1 isoform overexpression upregulates osteocalcin gene expression in non‐osteoblastic and pre‐osteoblastic cells , 1999, Journal of cellular biochemistry.

[39]  B. Schäfer,et al.  PAX3 and PAX7 exhibit conserved cis-acting transcription repression domains and utilize a common gain of function mechanism in alveolar rhabdomyosarcoma , 1999, Oncogene.

[40]  J A Epstein,et al.  Transgenic rescue of congenital heart disease and spina bifida in Splotch mice. , 1999, Development.

[41]  G. Karsenty,et al.  A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. , 1999, Genes & development.

[42]  G. Stein,et al.  Transient upregulation of CBFA1 in response to bone morphogenetic protein‐2 and transforming growth factor β1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation , 1999, Journal of cellular biochemistry.

[43]  A. McMahon,et al.  Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase , 1998, Current Biology.

[44]  P. Gruss,et al.  Pax3 and Pax7 are expressed in commissural neurons and restrict ventral neuronal identity in the spinal cord , 1998, Mechanisms of Development.

[45]  K. Takeda,et al.  Epistatic relationship between Waardenburg Syndrome genes MITF and PAX3 , 1998, Nature Genetics.

[46]  S. Mundlos,et al.  Cbfa1, a Candidate Gene for Cleidocranial Dysplasia Syndrome, Is Essential for Osteoblast Differentiation and Bone Development , 1997, Cell.

[47]  Makoto Sato,et al.  Targeted Disruption of Cbfa1 Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts , 1997, Cell.

[48]  G. Karsenty,et al.  Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation , 1997, Cell.

[49]  L A Herzenberg,et al.  Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[50]  G. Cossu,et al.  Redefining the Genetic Hierarchies Controlling Skeletal Myogenesis: Pax-3 and Myf-5 Act Upstream of MyoD , 1997, Cell.

[51]  H. Arnold,et al.  Gene targeting the myf‐5 locus with nlacZ reveals expression of this myogenic factor in mature skeletal muscle fibres as well as early embryonic muscle , 1996, Developmental dynamics : an official publication of the American Association of Anatomists.

[52]  J. Epstein,et al.  Pax3 modulates expression of the c-Met receptor during limb muscle development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[53]  S. E. Brodie New York, New York, USA , 1996 .

[54]  P. Gruss,et al.  Pax3: A paired domain gene as a regulator in PNS myelination , 1995, Neuron.

[55]  P. Tsonis,et al.  Expression of pax-6 during urodele eye development and lens regeneration. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[56]  J. Epstein,et al.  Pax3 Inhibits Myogenic Differentiation of Cultured Myoblast Cells (*) , 1995, The Journal of Biological Chemistry.

[57]  R. Krumlauf Hox genes in vertebrate development , 1994, Cell.

[58]  M. Rudnicki,et al.  MyoD or Myf-5 is required for the formation of skeletal muscle , 1993, Cell.

[59]  N M Le Douarin,et al.  The triple origin of skull in higher vertebrates: a study in quail-chick chimeras. , 1993, Development.

[60]  M. Goulding,et al.  Pax‐3, a novel murine DNA binding protein expressed during early neurogenesis. , 1991, The EMBO journal.

[61]  Manoel Luis Costa,et al.  MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[62]  S. Tapscott,et al.  Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[63]  J. Epstein,et al.  Pax 3 is required for enteric ganglia formation and functions with Sox 10 to modulate expression of cret , 2022 .